Stericycle Stock Hits New 52-Week High (SRCL)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Stericycle Incorporated (Nasdaq: SRCL) hit a new 52-week high Monday as it is currently trading at $96.04, above its previous 52-week high of $96 with 215,577 shares traded as of 2:41 p.m. ET. Average volume has been 477,500 shares over the past 30 days.

Stericycle has a market cap of $8.16 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 1.9% year to date as of the close of trading on Friday.

Stericycle, Inc., together with its subsidiaries, provides regulated waste management and related services. The company has a P/E ratio of 31.5, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Stericycle as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Stericycle Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Discovering a True Value

Discovering a True Value

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

Wide Moat, Bargain Price

Wide Moat, Bargain Price